Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR).

When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.

HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)
2022-02-22

[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam an ...>>

[Event Report] The 101st HGPI Seminar Looking Back at the History of Infectious Diseases to Think About the Future of AMR Countermeasures – A Seminar in Commemoration of AMR Awareness Month (November 24, 2021)
2022-02-01

[Event Report] The 101st HGPI Seminar Looking Back at the History of Infectious Diseases ...>>

[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Personal Opinion and Insight, December 20, 2021)
2022-01-14

[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Persona ...>>

[Event Report] The Third Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 17, 2021)
2021-12-27

[Event Report] The Third Meeting of Working Group 3 Under the Sub-committee on AMR of th ...>>

[Event Report] FY2022 AMR Alliance Japan Planning Meeting (December 6, 2021)
2021-12-23

[Event Report] FY2022 AMR Alliance Japan Planning Meeting (December 6, 2021)>>

[Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
2021-12-22

[Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infectio ...>>

[Publication Report] Incentivizing Resilience: Accelerating Efforts to Promote the Research and Development Needed to Save the World from the Next Pandemic (December 2, 2021)
2021-12-02

[Publication Report] Incentivizing Resilience: Accelerating Efforts to Promote the Resea ...>>

[Event Report] Investing in the Future: The Role of Investors in Saving the World from AMR (September 8, 2021)
2021-12-02

[Event Report] Investing in the Future: The Role of Investors in Saving the World from A ...>>

2021-11-26

[Research Report] Public Opinion Survery on the Threat of Antimicrobial Resistance (AMR) ...>>

[Publication Report] Taking Action for AMR Preparedness: Spurring Antibiotic Innovation for Healthy Ageing in Super-Ageing Japan (November 18, 2021)
2021-11-26

[Publication Report] Taking Action for AMR Preparedness: Spurring Antibiotic Innovation ...>>

[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR Alliance Japan, November 18, 2021)
2021-11-18

[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR ...>>

[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan – Following the 72nd Session of the World Health Organization Regional Committee for the Western Pacific, held in Himeji City, the City Government announced its participation in AMR Alliance Japan (November 17, 2021)
2021-11-17

[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan ...>>

PageTop